Campochiaro PA - Search Results

1

Suprachoroidal gene transfer with nonviral nanoparticles.

Shen J, Kim J, Tzeng SY, Ding K, Hafiz Z, Long D, Wang J, Green JJ, Campochiaro PA. Shen J, et al. Among authors: campochiaro pa. Sci Adv. 2020 Jul 3;6(27):eaba1606. doi: 10.1126/sciadv.aba1606. Print 2020 Jul. Sci Adv. 2020. PMID: 32937452 Free PMC article.

2

Deficiency of neuropilin 2 suppresses VEGF-induced retinal neovascularization.

Shen J, Samul R, Zimmer J, Liu H, Liang X, Hackett S, Campochiaro PA. Shen J, et al. Among authors: campochiaro pa. Mol Med. 2004 Jan-Jun;10(1-6):12-8. doi: 10.2119/2004-00017.campochiaro. Mol Med. 2004. PMID: 15502878 Free PMC article.

3

Oxidative damage is a potential cause of cone cell death in retinitis pigmentosa.

Shen J, Yang X, Dong A, Petters RM, Peng YW, Wong F, Campochiaro PA. Shen J, et al. Among authors: campochiaro pa. J Cell Physiol. 2005 Jun;203(3):457-64. doi: 10.1002/jcp.20346. J Cell Physiol. 2005. PMID: 15744744

4

Nonviral ocular gene transfer.

Kachi S, Oshima Y, Esumi N, Kachi M, Rogers B, Zack DJ, Campochiaro PA. Kachi S, et al. Among authors: campochiaro pa. Gene Ther. 2005 May;12(10):843-51. doi: 10.1038/sj.gt.3302475. Gene Ther. 2005. PMID: 15789063

5

Different effects of angiopoietin-2 in different vascular beds: new vessels are most sensitive.

Oshima Y, Oshima S, Nambu H, Kachi S, Takahashi K, Umeda N, Shen J, Dong A, Apte RS, Duh E, Hackett SF, Okoye G, Ishibashi K, Handa J, Melia M, Wiegand S, Yancopoulos G, Zack DJ, Campochiaro PA. Oshima Y, et al. Among authors: campochiaro pa. FASEB J. 2005 Jun;19(8):963-5. doi: 10.1096/fj.04-2209fje. Epub 2005 Mar 31. FASEB J. 2005. PMID: 15802489

6

Vascular targeting of ocular neovascularization with a vascular endothelial growth factor121/gelonin chimeric protein.

Akiyama H, Mohamedali KA, E Silva RL, Kachi S, Shen J, Hatara C, Umeda N, Hackett SF, Aslam S, Krause M, Lai H, Rosenblum MG, Campochiaro PA. Akiyama H, et al. Among authors: campochiaro pa. Mol Pharmacol. 2005 Dec;68(6):1543-50. doi: 10.1124/mol.105.015628. Epub 2005 Sep 8. Mol Pharmacol. 2005. PMID: 16150930

7

Suppression of ocular neovascularization with siRNA targeting VEGF receptor 1.

Shen J, Samul R, Silva RL, Akiyama H, Liu H, Saishin Y, Hackett SF, Zinnen S, Kossen K, Fosnaugh K, Vargeese C, Gomez A, Bouhana K, Aitchison R, Pavco P, Campochiaro PA. Shen J, et al. Among authors: campochiaro pa. Gene Ther. 2006 Feb;13(3):225-34. doi: 10.1038/sj.gt.3302641. Gene Ther. 2006. PMID: 16195704

8

Implication of the hypoxia response element of the Vegf promoter in mouse models of retinal and choroidal neovascularization, but not retinal vascular development.

Vinores SA, Xiao WH, Aslam S, Shen J, Oshima Y, Nambu H, Liu H, Carmeliet P, Campochiaro PA. Vinores SA, et al. Among authors: campochiaro pa. J Cell Physiol. 2006 Mar;206(3):749-58. doi: 10.1002/jcp.20525. J Cell Physiol. 2006. PMID: 16245301

9

Retinal degeneration from oxidative damage.

Cingolani C, Rogers B, Lu L, Kachi S, Shen J, Campochiaro PA. Cingolani C, et al. Among authors: campochiaro pa. Free Radic Biol Med. 2006 Feb 15;40(4):660-9. doi: 10.1016/j.freeradbiomed.2005.09.032. Epub 2005 Oct 21. Free Radic Biol Med. 2006. PMID: 16458197

10

Sustained expression after nonviral ocular gene transfer using mammalian promoters.

Kachi S, Esumi N, Zack DJ, Campochiaro PA. Kachi S, et al. Among authors: campochiaro pa. Gene Ther. 2006 May;13(9):798-804. doi: 10.1038/sj.gt.3302700. Gene Ther. 2006. PMID: 16467860

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

393 results

Search Page